As the glycosylation process seems to be conserved in higher eukaryotes our data suggest that a similar ALG10 defect in mammals should also lead to drastic protein hypoglycosylation resulting in severe metabolic diseases or developmental changes in other organisms. This evidence concerns the gene ALG10 and metabolic process.